NYSE:SQZ
Delisted
Sqz Biotechnologies Company Stock News
$0.0630
+0 (+0%)
At Close: Nov 28, 2023
SQZ Biotechnologies Company (SQZ) Reports Q1 Loss, Misses Revenue Estimates
08:31pm, Wednesday, 10'th May 2023
SQZ Biotechnologies Company (SQZ) came out with a quarterly loss of $0.60 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to loss of $0.75 per share a year ago.
SQZ Biotechnologies to Present at Upcoming Investor Conferences
04:30pm, Wednesday, 07'th Sep 2022
WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies Company (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that Armon Sharei,
Biopharmaceutical Stocks: The Bottoming Process Is Playing Out
02:30pm, Wednesday, 08'th Jun 2022
Three weeks ago, I suggested that the severe correction in biopharmaceutical stocks had ended. I expect the bottoming process to be choppy with a bias to the upside. The antecedent cause of the declin
SQZ Biotechnologies to Present at Jefferies Healthcare Conference
04:45pm, Wednesday, 01'st Jun 2022
WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that Armon Sharei, Ph.D.,
SQZ Biotechnologies to Present at Upcoming Investor Conferences
04:45pm, Wednesday, 06'th Apr 2022
WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that Armon Sharei, Ph.D.,
WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies Company (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that it will prese
SQZ Biotechnologies' Cell Therapy Shows Favorable Safety Profile In HPV+ Solid Tumors
01:31pm, Thursday, 02'nd Dec 2021
SQZ Biotechnologies Company (NYSE: SQZ) announced interim results from the highest-dose monotherapy cohort of Phase 1/2 trial of SQZ-PBMC-HPV in Human Papillomavirus positive (HPV16+) solid tumors.
SQZ Biotechnologies to Present at the 4th Annual Evercore ISI HealthCONx Conference
04:45pm, Monday, 29'th Nov 2021
WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that management will be pr
SQZ Biotechnologies to Present at the Stifel 2021 Virtual Healthcare Conference
04:45pm, Monday, 15'th Nov 2021
WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies (NYSE:SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that management will be pre
SQZ Biotechnologies to Present New Data at the Society for Immunotherapy of Cancer Annual Meeting
06:45am, Monday, 04'th Oct 2021
WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that it will present updat
SQZ Biotechnologies to Present at the Chardan 5th Annual Genetic Medicines Conference
04:45pm, Thursday, 30'th Sep 2021
WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that management will be pr
SQZ Biotechnologies to Present at Cantor Global Healthcare Conference
04:45pm, Monday, 27'th Sep 2021
WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that management will be pr
SQZ Biotechnologies Announces First Autoimmune Disease Indication for Tolerizing Antigen Carrier (TAC) Platform
06:45am, Monday, 13'th Sep 2021
WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that the first clinical tr
SQZ Biotechnologies to Present at Upcoming Health Care Conferences
06:45am, Thursday, 09'th Sep 2021
WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that management will be pr
SQZ Biotechnologies Reports Second Quarter 2021 Financial Results and Recent Portfolio Updates
04:54pm, Wednesday, 04'th Aug 2021
WATERTOWN, Mass.--(BUSINESS WIRE)--SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today reported second quarter 2021 financi
